In a groundbreaking effort to revolutionize the treatment of heart rhythm disorders, the University of Miami Miller School of Medicine is leading the charge in personalizing patient care. The cardiac electrophysiology group at the institution is pioneering innovative research and treatment strategies for patients with abnormal heart rhythms, particularly atrial fibrillation.
Under the leadership of Dr. Jeffrey Goldberger, the team is making significant strides in understanding atrial fibrillation through advanced methods like catheter ablation. Despite the procedure’s stagnant success rate of 60%, Dr. Goldberger advocates for a more personalized approach to treatment, tailoring strategies based on genetics, age, body composition, and other factors.
Innovative Research and Personalized Care
Dr. Goldberger’s research emphasizes the importance of moving beyond a one-size-fits-all approach. His team utilizes cutting-edge technologies, including artificial intelligence and genetic testing, alongside lifestyle interventions. This holistic approach aims to enhance patient outcomes and pave the way for future breakthroughs in cardiac care.
Dr. Raul Mitrani, a key collaborator, highlights the team’s dedication to personalizing medicine for a broad range of patients. The group operates one of Florida’s only comprehensive risk factor management centers for atrial fibrillation. They offer customized treatment plans, addressing factors such as weight, blood pressure, and sleep apnea, in conjunction with medical interventions.
Research Beyond Borders
The group’s commitment to advancing cardiac care is evident in its participation in several federally funded research projects. Among these is the Liraglutide Effect on Atrial Fibrillation (LEAF) study, which explores the impact of weight-loss drugs on treatment outcomes. The findings suggest a potential doubling of success rates for catheter ablation when combined with adjunctive strategies.
Other notable projects include the OMICS study, which investigates the role of epicardial adipose tissue in atrial fibrillation risk, and the development of 4D Flow MRI technology to better assess stroke risk.
Future Directions
Dr. Goldberger acknowledges the progress made but emphasizes the need for continued innovation. “There have been many real improvements in our approach to atrial fibrillation, but we still have a long, long way to go to get to optimal treatment,” he stated in the original article. The team’s focus remains on identifying gaps and areas for impactful advancements in cardiac care.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Bluerate.ai—formerly MyMortgageRates—is stepping into 2025 with a mission to modernize a mortgage process that has barely changed in decades. Built by Zeitro, the platform equips both borrowers and loan officers with powerful AI tools, from online pre‑qualification and automated financial data extraction to instant guideline answers and scenario analysis. With more than 3,000 verified NMLS‑licensed loan officers and real‑time rate comparisons from major lenders, Bluerate.ai is quickly becoming a must‑know platform for mortgage and real estate professionals seeking speed, clarity, and a fully digital lending experience.
After the longest government shutdown in U.S. history, key federal housing programs such as FHA, VA, USDA, and NFIP are officially back in operation—offering long‑awaited relief to agents, lenders, and insurance professionals. But with a six‑week backlog slowing everything from loan guarantees to flood-insurance renewals, real estate pros should brace for delays and focus on resetting client expectations. A new federal spending deal restores funding through early 2026 and gives the market room to breathe, while NAR’s aggressive advocacy helped push the government toward reopening. Now, professionals who communicate clearly and stay on top of regulatory updates will be best positioned to guide clients through the temporary turbulence.
Commercial real estate is rapidly shifting toward a digital-first model, with platforms like Crexi leading the charge. By unifying property data, AI-driven insights, transparent bidding, and streamlined transaction tools, digital marketplaces are becoming essential to how modern CRE deals are sourced, analyzed, and closed. With more than 2 million monthly users and over $1 trillion in facilitated transactions, Crexi showcases how technology is reshaping the industry and giving real estate professionals a powerful competitive edge.
Europe’s biggest landlords—including Aroundtown, Vonovia, and top global investors—have teamed up to launch ATechX, a powerful new accelerator giving proptech startups something they rarely get: access to real buildings, real customers, and a clear path to scale across multiple countries. Designed to move founders beyond “pilot purgatory,” ATechX offers a true sandbox for innovation in Europe’s aging, regulation‑heavy property market, helping promising technology reach commercial traction faster than ever.
Mortgage rates are finally easing, inventory is climbing, and buyers are gaining leverage for the first time in years — yet sky‑high prices and economic jitters are keeping many on pause. With economists warning that inflation could push rates higher again, this fall may offer a rare window for well‑prepared buyers. Here’s what’s driving the shift, where opportunities are emerging, and how real estate professionals can stay ahead.
Griffin Funding has appointed John Jones as Senior Vice President of Growth and EOS Integrator, aiming to scale the company toward a $3 billion annual non-QM volume goal by 2030. After serving in fractional leadership roles since April 2025, Jones now steps in full‑time to lead organizational structure, efficiency, market expansion, and cross‑department alignment. Backed by strong liquidity and rising deal volume, Griffin Funding appears positioned for major industry impact in the years ahead.
